Stephen Newlin - Chemours Independent Director
| CC Stock | MXN 451.24 0.00 0.00% |
Director
Mr. Stephen D. Newlin has appointed as Independent Director of the Company with effect on July1, 2015. Mr. Newlin has served as President and Chief Executive Officer of Univar Inc., a leading global distributor of chemicals, supplying products and services, since May 2016. In November 2016, he was appointed Chairman of the Board of Directors for Univar. He previously served as the Chairman, President and Chief Executive Officer of PolyOne Corporation from 2006 to 2014, and was Executive Chairman of the Board until 2016. Prior to joining PolyOne, Mr. Newlin served as President Industrial Sector of Ecolab Inc. from 2003 to 2006. He also served as President and Director of Nalco Chemical Company from 1998 to 2001, and was Vice Chairman, President, and Chief Operating Officer from 2000 to 2001. He currently serves on the board of directors of Univar Inc. since 2014 and of Oshkosh Corporation since 2013. Mr. Newlin served on the boards of the Black Hills Corporation from 2004 to 2015, and The Valspar Corporation from 2007 to 2012. since 2015.
| Age | 63 |
| Tenure | 9 years |
| Phone | 302 773 1000 |
| Web | https://www.chemours.com |
Chemours Management Efficiency
The company has return on total asset (ROA) of 0.0653 % which means that it generated a profit of $0.0653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5281 %, meaning that it generated $0.5281 on every $100 dollars invested by stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Guillermo Martinez | Vitro SAB de | 70 | |
| Joaquin Guajardo | Vitro SAB de | 65 | |
| Andres Herrera | ALPEK SAB de | 52 | |
| Mario Gomez | Vitro SAB de | 64 | |
| Ricardo Bringas | Vitro SAB de | 56 | |
| Hernan Corral | ALPEK SAB de | N/A | |
| Jaime Puche | ALPEK SAB de | 67 | |
| Merici Sada | ALPEK SAB de | 61 | |
| Alvaro Garza | ALPEK SAB de | 51 | |
| Jaime Puche | Vitro SAB de | 67 | |
| Federico Melo | Vitro SAB de | 34 | |
| Enrique Benitez | ALPEK SAB de | N/A | |
| Francisco Rojas | ALPEK SAB de | 53 | |
| Rodrigo Martinez | ALPEK SAB de | 43 | |
| Alvaro Garza | Vitro SAB de | 51 | |
| David Guzman | Vitro SAB de | 62 | |
| Joaquin Thurlow | Vitro SAB de | 62 | |
| Jaime Garza | Vitro SAB de | 59 | |
| Ricardo Touche | Vitro SAB de | 71 | |
| Pierre Garcia | ALPEK SAB de | 67 | |
Management Performance
| Return On Equity | 0.53 | |||
| Return On Asset | 0.0653 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dawn Farrell, Independent Director | ||
| Curtis Anastasio, Independent Director | ||
| Bryan Snell, President - Titanium Technologies | ||
| Jonathan Lock, Sr Officer | ||
| Stephen Newlin, Independent Director | ||
| David Shelton, Corporate Secretary and General Counsel | ||
| Paul Kirsch, President - Fluoroproducts | ||
| Curtis Crawford, Independent Director | ||
| Mary Cranston, Independent Director | ||
| Bradley Bell, Independent Director | ||
| Erin Kane, Independent Director | ||
| Christian Siemer, President - Chemical Solutions | ||
| Alisha Bellezza, Director of Investor Relations | ||
| Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
| Eugene Snell, President - Titanium Technologies | ||
| Kurt Bonner, Ma Relations | ||
| Elizabeth Albright, Senior Vice President - Human Resources | ||
| Kristine Wellman, Gen VP | ||
| Sean Keohane, Director | ||
| Thierry Vanlancker, President - Fluoroproducts | ||
| Sameer Ralhan, CFO, Senior Vice President Treasurer | ||
| Camela Wisel, Chief VP | ||
| Mark Newman, CFO, Senior Vice President | ||
| Edwin Sparks, President - Chemical Solutions | ||
| Erich Parker, Vice President of Corporate Communications, Chief Brand Officer | ||
| Mark Vergnano, President CEO, Director | ||
| Lori Ursomarso, IR Contact Officer | ||
| Richard Brown, Chairman of the Board | ||
| Alvenia Scarborough, Sr Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.53 | |||
| Return On Asset | 0.0653 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 146.34 B | |||
| Shares Outstanding | 148.5 M | |||
| Shares Owned By Insiders | 1.09 % | |||
| Shares Owned By Institutions | 77.77 % | |||
| Price To Earning | 82.94 X | |||
| Price To Book | 3.61 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chemours in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chemours' short interest history, or implied volatility extrapolated from Chemours options trading.
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving together with Chemours Stock
| 0.7 | VITROA | Vitro SAB de Earnings Call This Week | PairCorr |
Moving against Chemours Stock
| 0.78 | ECL | Ecolab Inc Earnings Call This Week | PairCorr |
| 0.56 | IDEALB-1 | Impulsora del Desarrollo | PairCorr |
| 0.45 | ALPEKA | ALPEK SAB de Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Chemours to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Chemours. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |